- Home
- BLRX vs ZCMD Comparison
BLRX vs ZCMD Comparison
Compare BLRX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- ZCMD
- Stock Information
- Founded
- BLRX 2003
- ZCMD 2012
- Country
- BLRX Israel
- ZCMD China
- Employees
- BLRX N/A
- ZCMD N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- BLRX Health Care
- ZCMD Real Estate
- Exchange
- BLRX Nasdaq
- ZCMD Nasdaq
- Market Cap
- BLRX 17.1M
- ZCMD 16.8M
- IPO Year
- BLRX 2011
- ZCMD 2020
- Fundamental
- Price
- BLRX $3.40
- ZCMD $0.56
- Analyst Decision
- BLRX Strong Buy
- ZCMD
- Analyst Count
- BLRX 2
- ZCMD 0
- Target Price
- BLRX $19.00
- ZCMD N/A
- AVG Volume (30 Days)
- BLRX 24.1K
- ZCMD 28.3K
- Earning Date
- BLRX 11-24-2025
- ZCMD 01-01-0001
- Dividend Yield
- BLRX N/A
- ZCMD N/A
- EPS Growth
- BLRX N/A
- ZCMD N/A
- EPS
- BLRX N/A
- ZCMD N/A
- Revenue
- BLRX $12,735,000.00
- ZCMD $13,117,523.00
- Revenue This Year
- BLRX N/A
- ZCMD N/A
- Revenue Next Year
- BLRX N/A
- ZCMD N/A
- P/E Ratio
- BLRX N/A
- ZCMD N/A
- Revenue Growth
- BLRX N/A
- ZCMD N/A
- 52 Week Low
- BLRX $2.30
- ZCMD $0.54
- 52 Week High
- BLRX $14.70
- ZCMD $2.50
- Technical
- Relative Strength Index (RSI)
- BLRX 50.28
- ZCMD 44.51
- Support Level
- BLRX $3.20
- ZCMD $0.54
- Resistance Level
- BLRX $3.53
- ZCMD $0.69
- Average True Range (ATR)
- BLRX 0.21
- ZCMD 0.06
- MACD
- BLRX 0.03
- ZCMD 0.00
- Stochastic Oscillator
- BLRX 93.02
- ZCMD 57.89
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.